KaydedilenlerDerginizi ekleyin

Dergiler / Kocaeli Tıp Dergisi / 2018 / Cilt: 7 - Sayı: 2

Minimal Change Disease and Toxic Hepatitis Due to Ecstasy

Ekstaziye Bağlı Toksik Hepatit ve Minimal Değişiklik Hastalığı

İlter BOZACI
Garip ŞAHİN
Mustafa AÇIKALIN
Sayfa
45–49
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In our case, we wanted to mention that MCD cases can come with atypical clinical findings and we should keep ecstasy abuse in mind as secondary reason at these types of cases.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Minimal change disease (NIL (Nothing In Light microscope) disease) is the most common cause of nephrotic syndrome in childhood; and one of the most common causes of nephrotic syndrome in adults.
📊
Temel Bulgular & Veri:Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is a synthetic psychoactive compound with C11H15NO2 formula.
💡
Sonuç & Katkı:In our case, we wanted to mention that MCD cases can come with atypical clinical findings and we should keep ecstasy abuse in mind as secondary reason at these types of cases.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Minimal change disease (NIL (Nothing In Light microscope) disease) is the most common cause of nephrotic syndrome in childhood; and one of the most common causes of nephrotic syndrome in adults. Characteristic findings are: diffuse foot process effacement in electrone microscopy, no complement or immunoglobulin deposits on immunofluorescence microscopy , severe functional defect in glomerular permselectivity. Most cases of MCD are idiopathic or primary. Secondary MCD is associated with the following: drugs, tumors, allergy, infections and other glomerular diseases. Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is a synthetic psychoactive compound with C11H15NO2 formula. Malign hypertension, tachycardia, hyperthermia, acute kidney failure, hyponatremia, rhabdomyolisis, neurologic symptoms like agitation, anxiety, hepatotoxicity can be seen due to ecstasy abuse. In our case, we wanted to mention that MCD cases can come with atypical clinical findings and we should keep ecstasy abuse in mind as secondary reason at these types of cases.

Abstract

Minimal değişiklik hastalığı(MDH), NIL hastalığı, çocuklarda nefrotik sendromun en sık nedeni iken erişkinlerde de nefrotik sendromun en önemli nedenlerindendir. Elektron mikroskopta ayaksı çıkıntılarda yaygın yapışıklık olması; immünfloresan mikroskopta depolanma olmaması; glomerüllerin seçici geçirgenliğinde şiddetli fonksiyon kaybı karakteristik bulgularıdır. MDH, sıklıkla idiopatiktir. MDH ile ilişkili sekonder nedenler ise ilaçlar, tümörler, allerji, enfeksiyonlar ve diğer glomerüler hastalıklardır. Ekstazi (3,4 metilendioksi -N-metilamfetamin, MDMA) C11H15NO2 formülüne sahip psikoaktif bir maddedir. Kullanımına bağlı ortaya çıkan etkiler arasında malign hipertansiyon, taşikardi, hipertermi, akut böbrek yetmezliği, hiponatremi, rabdomyoliz, ajitasyon, anksiyete, hepatotoksisite yer almaktadır. Olgumuzda, MDH’nın atipik klinik bulgularının olabileceğini ve benzer bulgularla gelen olgularda sekonder nedenler arasında ekstazi kullanımının da akılda tutulması gerektiğini vurgulamayı amaçladık.

🔖

Bu Makaleye Atıf Yap

BOZACI, İ., ŞAHİN, G., AÇIKALIN, M. (2018). Minimal Change Disease and Toxic Hepatitis Due to Ecstasy. Kocaeli Tıp Dergisi, Cilt: 7 - Sayı: 2, 45–49. https://ajindex.com/articles/200054

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Nephrotic syndrome in children: prediction of histopathologyfromclinicalandlaboratorycharacteris tics at time of diagnosis. A report of the International Study of KidneyDisease in Children. KidneyInt 1978; 13:159-61. Cameron JS. The nephroticsyndrome and its complications. Am J KidneyDis 1987; 10:157-9.
  2. Meyrier A, Niaudet P. Minimal changesandfocal-segmentalglomerulosclerosis. In: Oxford Textbook of ClinicalNephrology, 3rd ed, Davison AM, Cameron JS, Grünfeld E, et al (Eds), Oxford UniversityPress, Oxford 2005. Vol 1, p.439. Mason PD. Minimal change disease and primary focal segmental glomerulosclerosis. In: Comprehensive Clinical Nephrology, 2nd ed, Johnson RJ, Feehally J (Eds), Elsevier, Philadelphia 2000. p.271. Almansori M, Kovithavongs T, Qarni MU. Cyclooxygenase-2 inhibitor-associated minimalchangedisease. ClinNephrol 2005; 63:381-2. Glassock RJ. Secondary minimal change disease. Nephrol Dial Transplant 2003; 18 Suppl 6:vi52. Lecoules S, Duvic C, Hérody M, Nédélec G. [Tiopronin-induced nephrotic syndrome with minimal glomerular lesions]. Presse Med 1999; 28:273-4.
  3. Aoyama M, Sugimoto T, Yokono T, et al. Minimal-change nephropathy and chronic hepatitis C infection: coincidental or associated? Nephrol Dial Transplant 2007; 22:1479-1482.
  4. Dabbs DJ, Striker LM, Mignon F, Striker G. Glomerular lesions in lymphomas and leukemias. Am J Med 1986; 80:63-6.
  5. Meyrier A, Delahousse M, Callard P, Rainfray M. Minimal change nephrotic syndrome revealing solid tumors. Nephron 1992; 61:220-1.
  6. Auguet T, Lorenzo A, Colomer E, et al. Recovery of minimal change nephroticsyndrome and acute renal failure in a patient with Renal cell carcinoma. Am J Nephrol 1998; 18:433-4.
  7. Kwiatkowska E, Gołembiewska E, Ciechanowski K, Kędzierska K. Minimal-Change Disease Secondary to Borrelia burgdorferi Infection. Case RepNephrol 2012; 2012:294532. Boix E, Rivera F, Gil CM, et al. Steroidresponsive nephrotic syndrome with minimalchange disease and IgA deposits in a HIV-infected patient. Nephrol Dial Transplant 2000; 15:412-4.
  8. Abdel-Hafez M, Shimada M, Lee PY, et al. Idiopathic nephrotic syndrome and atopy: is there a common link? Am J KidneyDis 2009; 54:945-7.
  9. Lai KN, Lai FM, Chan KW, et al. An overlapping syndrome of IgA nephropathy and lipoidnephrosis. Am J ClinPathol 1986; 86:716-7.
  10. Dube GK, Markowitz GS, Radhakrishnan J, et al. Minimal change disease in systemic lupus erythematosus. ClinNephrol 2002; 57:120-3. Rao PS. Nephrotic syndrome in patients with peripheral blood stemcell transpla